Coverage
-
May 15, 2015
Mylan Pharmaceuticals Inc. told a Pennsylvania federal judge Thursday that it would urge the Third Circuit to overturn his ruling that tossed the generic-drug maker's allegations that Warner Chilcott PLC tried to block generic competition for its acne medication Doryx by tweaking its formula.
10 other articles on this case.
View all »